ACE2 mRNA expression was described to be increased in renal papillary cell carcinoma and colon and pancreatic adenocarcinomas, and decreased in kidney chromophobe, testicular germ cell tumours, and thyroid cancer [7,8,9]. The gene discussed is ACE2; the disease is thyroid gland carcinoma.